Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 October 2005, Vol. 106, No. 8, pp. 2922-2923.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porto, G.
Right arrow Articles by Camaschella, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porto, G.
Right arrow Articles by Camaschella, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CORRESPONDENCE

To the editor:

A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron

Mutations of hepcidin are a rare cause of juvenile hemochromatosis (JH). We report a homozygous -25G>A mutation in the hepcidin 5' untranslated region (UTR) that generates a new start codon with a consequent frameshift. In this patient with a rare coincidental association of JH, Turner syndrome, and absolute lymphopenia, the absence of normal hepcidin synthesis was expected. Surprisingly, the patient had detectable hepcidin, suggesting that the start of translation was maintained at the original ATG with some normal protein production. However, hepcidin was not appropriately induced by an iron challenge test, supporting role of hepcidin on the clinical expression of iron overload in this case.

The hepatic peptide hepcidin is a key regulator of iron balance.1 Mutations of hepcidin are a rare cause of juvenile hemochromatosis (JH),2-3 and include nonsense, frameshift,2 and missense mutations C70R and C78T affecting conserved cysteines.3-5

Recently a -25G>Amutation in the HAMP 5'UTR was described in 2 Portuguese siblings with iron overload and absence of urinary hepcidin.6 Here, the same mutation was found in a different Portuguese family where the proband shows coincidental association of JH, Turner syndrome, and absolute lymphopenia.7 Although no comparative haplotype analysis was performed, geographic and historical tracking does not indicate any relationship with the previously described family. In the proband, no mutations in the coding regions of HAMP and hemojuvelin genes were found by sequencing.3,8 However, in the 5'UTR region of HAMP, a G>A point mutation was identified at position -25 from the canonical ATG. This was confirmed by WAVE (Transgenomic, Omaha, NE) denaturing high-performance liquid chromatography (DHPLC; heteroduplexes were formed by heat denaturation at 94°C for 3 minutes and cooling to 25°C for 45 minutes; the mixture was analyzed at a melting temperature of 64.1°C, with a linear acetonitrile gradient: Start: 44.3% Buffer A, 55.7% Buffer B; Stop: 35.3% Buffer A, 64.7% Buffer B). In a family study performed with written informed consent, both parents and one brother were heterozygous for the mutation. Elevated serum ferritin levels in these subjects were likely due to the additional effect of regular high alcohol intake.

The G>A substitution changes GTG to ATG and creates a new start site for translation. Since this mutation introduces an earlier initiation codon with a shifted reading frame, it would be expected to encode a different peptide. Surprisingly, urinary hepcidin, analyzed in first morning voided samples,9 was detected in the proband at a concentration of 12 ng/mg creatinine with a serum ferritin concentration of 19 ng/mL at the time of evaluation. The result was confirmed by Western blot analysis. The production of hepcidin could be explained by the maintenance of the start of translation at the original ATG, a phenomenon also observed with other genes.10 In this case, urinary hepcidin was evaluated when iron depletion had been already achieved by phlebotomy treatment. To explain the initial severe phenotype of the patient, we hypothesized that hepcidin was not appropriately induced by iron and performed an iron challenge test with urinary hepcidin determination 24 hours after the ingestion of 80 mg iron as ferrous sulfate.9 No increase in urinary hepcidin was observed in the patient, in contrast with a 2- to 3-fold increase observed in 2 control subjects (Figure 1). Of interest, a reduction in serum transferrin saturation was observed in controls 24 hours after the iron challenge (Figure 1). In contrast, the transferrin saturation in the patient increased with the iron challenge. We interpret the late reduction of transferrin saturation in the controls as a delayed effect of hepcidin increase. The lack of this response in the patient supports the notion that defective hepcidin regulation played a role in her iron overload.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 1.. Urinary hepcidin levels in 2 controls and the proband, before and after ingestion of 80 mg iron as ferrous sulfate. Synthetic hepcidin standards (20, 50, and 100 ng) and urinary extracts equivalent to 0.5 mg creatinine were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting with rabbit anti-human hepcidin antibody. 0 = urine collected before iron ingestion; Fe = urine collected 24 hours after iron ingestion. Measures of urinary hepcidin, serum transferrin saturation, and serum ferritin are given for each subject at the indicated test times.

 
Acknowledgements

The authors wish to acknowledge nurse Graça Melo for her work on the recruitment, organization, and collection of samples for the family study.

Graça Porto, Antonella Roetto, Filomena Daraio, Jorge Pereira Pinto, Susana Almeida, Conceição Bacelar, Elizabeth Nemeth, Tomas Ganz, and Clara Camaschella

Correspondence: Graça Porto, ICBAS, Abel Salazar Institute for the Biomedical Sciences, 4100, Porto, Portugal; e-mail: gporto{at}ibmc.up.pt.

Partially supported by Telethon, Rome and Ministero dell'Istruzione, dell'Università e della Ricerca, Fondo per gli Investimenti della Ricerca di Base (MIUR FIRB) to C.C.; and the Gulbenkian Foundation and the Portuguese Foundation for Science and Technology (FCT).

References

  1. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102: 783-788.[Abstract/Free Full Text]

  2. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33: 21-22.[CrossRef][Medline] [Order article via Infotrieve]

  3. Roetto A, Daraio F, Porporato P, et al. Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). Blood. 2004;103: 2407-2409.[Abstract/Free Full Text]

  4. Majore S, Binni F, Pennese A, De Santis A, Crisi A, Grammatico P. HAMP gene mutation c.208T>C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis. Hum Mutat. 2004;4: 400.

  5. Delatycki M, Allen K, Gow P, et al. A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant hemochromatosis. Clin Genet. 2004;65: 378-383.[CrossRef][Medline] [Order article via Infotrieve]

  6. Matthes T, Aguilar-Martinez P, Pizzi-Bosman L, et al. Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'UTR of the HAMP gene. Blood. 2004;104: 2181-2183.[Abstract/Free Full Text]

  7. Porto G, Cruz E, Pessegueiro Miranda H, et al. Growth hormone (GH)-induced reconstitution of CD8+CD28+ T lymphocytes in a rare case of severe lymphopenia associated with juvenile hemochromatosis and Turner's syndrome. Clin Endocr. 2004;61: 437-440.

  8. Lanzara C, Roetto A, Daraio F, et al. The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood. 2004;103: 4317-4321.[Abstract/Free Full Text]

  9. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113: 1271-1276.[CrossRef][Medline] [Order article via Infotrieve]

  10. Kanaji T, Okamura T, Osaki K, et al. A common genetic polymorphism in the 5'-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood. 1998;6: 2010-2014.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
H. K. Bayele and S. K. S. Srai
Genetic variation in hepcidin expression and its implications for phenotypic differences in iron metabolism
Haematologica, September 1, 2009; 94(9): 1185 - 1188.
[Full Text] [PDF]


Home page
haematolHome page
M.-L. Island, A.-M. Jouanolle, A. Mosser, Y. Deugnier, V. David, P. Brissot, and O. Loreal
A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis
Haematologica, May 1, 2009; 94(5): 720 - 724.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
L. Valenti, E. A. Pulixi, P. Arosio, L. Cremonesi, G. Biasiotto, P. Dongiovanni, M. Maggioni, S. Fargion, and A. L. Fracanzani
Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis
Haematologica, August 1, 2007; 92(8): 1037 - 1042.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. Rideau, B. Mangeat, T. Matthes, D. Trono, and P. Beris
Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis
Haematologica, January 1, 2007; 92(1): 127 - 128.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Camaschella
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
Blood, December 1, 2005; 106(12): 3710 - 3717.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porto, G.
Right arrow Articles by Camaschella, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porto, G.
Right arrow Articles by Camaschella, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020